Scientific article
Case report
OA Policy
English

Anaphylactic shock and cardiac arrest after intravenous injection of sulphur hexafluoride SonoVue

Published inBMJ case reports, vol. 17, no. 11, e262018
Publication date2024-11
First online date2024-11-28
Abstract

A male patient in his early 60s was referred to the cardiology department for evaluation of a persistent apical ventricular thrombus following a myocardial infarction. Transthoracic echocardiography could not rule out the presence of an apical thrombus, leading to the intravenous administration of the contrast agent sulphur hexafluoride (SonoVue). The patient quickly exhibited signs of anaphylaxis accompanied by haemodynamic shock, resulting in cardiac arrest. He was successfully resuscitated with no significant secondary neurological impairment. According to the European Medicines Agency, anaphylactic reactions to the contrast agent sulphur hexafluoride (SonoVue) occur in approximately 1 in 10 000 cases. To our knowledge, this represents the first case of hypersensitivity to sulphur hexafluoride (SonoVue) confirmed by positive in vitro testing.

Keywords
  • Cardiovascular system
  • Contraindications and precautions
  • Drug interactions
  • Safety
  • Unwanted effects / adverse reactions
Citation (ISO format)
NIGOLIAN, Ani et al. Anaphylactic shock and cardiac arrest after intravenous injection of sulphur hexafluoride SonoVue. In: BMJ case reports, 2024, vol. 17, n° 11, p. e262018. doi: 10.1136/bcr-2024-262018
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1757-790X
37views
218downloads

Technical informations

Creation17/03/2025 08:43:40
First validation31/03/2025 06:22:49
Update31/03/2025 06:22:49
Status update31/03/2025 06:22:49
Last indexation31/03/2025 06:22:50
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack